CPT code 93641 covers testing of implanted single- or dual-chamber implantable cardioverter-defibrillator (ICD) leads and the device pulse generator at the time of initial implantation or replacement. Nationally, this code reflects a critical peri-procedural service that ensures device integrity and patient safety by confirming lead function, sensing, pacing, and the generator’s power systems during implantation events. Appropriate coding and documentation for 93641 affect facility and professional claims during device implantation episodes and influence national utilization patterns for cardiac device procedures.

Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication provides comparative benchmarks and coding guidance context, focusing on how payers cover and reimburse device testing services tied to ICD implantation and replacement. Readers will find: payer coverage and reimbursement benchmarks; clinical context explaining when 93641 is reported (initial implant or replacement); and practical billing considerations including common modifiers and claim components. Data not available in the input for specific payer rates, associated taxonomies, and ICD-10 diagnoses are noted where relevant. The material is intended for billing managers, proceduralists, and policy analysts seeking a concise national overview of CPT code 93641 in the context of cardiac device implantation services.